![]() |
|
|
Vol. 283, Issue 2, 925-931, 1997
q and G
i1
Department of Pharmacology, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania
| |
Abstract |
|---|
|
|
|---|
Desensitization of alpha-1 adrenoceptor
(
1AR)-mediated responses in aortic smooth muscle after
exposure to catecholamines or
1AR agonists has been
widely demonstrated. To determine whether exposure to an
1AR agonist results in desensitization of
1AR-mediated responses in a resistance artery, rat tail
artery rings were exposed to 7.5 or 75 µM phenylephrine (PE) for 22 hr in vitro. Norepinephrine-stimulated contraction was
significantly reduced in PE-exposed tail artery rings. Contractions
mediated by the
2AR agonists, clonidine and UK 14,304, and by serotonin were also reduced in PE-treated tail artery rings.
However, the contractile responses to KCl and ionomycin remained
unchanged. Norepinephrine-, PE-, endothelin- and serotonin-stimulated inositol phosphate accumulations were reduced in PE-exposed tail artery
rings, whereas KCl- and ionomycin-stimulated inositol phosphate accumulation remained unchanged. The density of membrane
1ARs, measured by specific
[125I]2-{[
-(4-hydroxyphenyl)ethyl]aminomethyl}-1-etralone
binding was not changed in PE-desensitized tail arteries. Further
studies were performed to examine if alterations in receptor/G protein interaction accompanies arterial desensitization. In these studies receptor-stimulated increases in [35S]GTP
S binding to
G proteins was assessed in membranes obtained from vehicle (control)
and PE-treated tail arteries. In control membranes
1AR
stimulation increased [35S]GTP
S binding to
G
q and G
i proteins, whereas the
2AR agonist UK14,304 activated
[35S]GTP
S binding to G
i exclusively.
Both PE- and UK14,304-induced responses were reduced in membranes from
tail arteries that were exposed to either 7.5 or 75 µM PE for 22 hr.
Western blot analyses of G protein alpha and
beta subunits demonstrated that G
q and
G
i protein levels were decreased in PE-exposed tail
artery membranes. These data show that the reduced transmembrane
signaling for the
1AR in tail artery after in
vitro PE exposure is associated with decreases in
G
q and G
i protein levels. The reduction in these G
proteins also appears to mediate the loss of
function of
2AR and perhaps of other G protein-coupled
receptors.
| |
Introduction |
|---|
|
|
|---|
Alpha-1
adrenergic signal transduction in the aorta, a conduit vessel,
undergoes desensitization after prolonged exposure to catecholamines or
1AR agonists in vivo (Maze et
al., 1985
; Rosenbaum et al., 1986
; Tsujimoto et
al., 1987
; Hiremath et al., 1991
; Johnson et
al., 1991a
, b) or in vitro (Lurie, et al.,
1985
; Hu et al., 1992a
,b
, 1994
). The desensitization of the
contractile response extends to responses mediated by other G
protein-coupled receptors (Maze et al., 1985
; Rosenbaum
et al., 1986
; Tsujimoto et al., 1987
; Hu et
al., 1994
). Ligand binding studies with aortic membranes (Lurie
et al., 1985
; Seasholtz et al., 1997
) or
DDT1 MF2 smooth muscle cell
membranes (Leeb-Lundberg et al., 1987
) have shown that
1AR density is not affected by treatments that elicit receptor desensitization. These results have previously led us
to postulate that
1AR desensitization may be
associated with alterations at a site(s) distal to the receptor. In
studies performed on aorta, we have demonstrated that chronic NE
infusion results in reduced
1AR-mediated
functions and that this desensitization is mediated by a reduction in
receptor/G protein coupling (Johnson et al., 1991b
;
Seasholtz et al., 1997
).
Very little is known concerning the effects of prolonged catecholamine
or
1AR agonist exposure on resistance vessels
such as the rat tail artery, despite evidence that resistance artery tone has a greater impact on blood pressure than does the tone of
larger vessels such as the aorta. In addition, results have shown that
tail arteries from spontaneously hypertensive rats have an increased
contractile response to receptor stimulation when compared with tail
arteries from normotensive Wistar-Kyoto rats (Vila et al.,
1993
). Increased contractility is not seen in aortas of spontaneously
hypertensive rats (Vila et al., 1993
), which indicates that
resistance arteries may play a role in the pathophysiology of some
forms of hypertension. In the present study, we investigate whether the
tail artery does in fact undergo desensitization, and if so, identify
the possible mechanisms involved in resistance artery desensitization.
| |
Materials and Methods |
|---|
|
|
|---|
In Vitro Phenylephrine Exposure
Male Sprague-Dawley rats (200-300 g) were decapitated. Tail arteries were dissected, cut into 5-mm rings and placed in conical tubes containing sterile DPBS on ice. Arteries were then transferred to 25-cm2 tissue culture flasks containing 10 ml Dulbecco's modified Eagle's medium with 250 U/ml penicillin/streptomycin and placed in a 37°C incubator containing 5% CO2. Vessels were permitted to equilibrate for 1 to 2 hr before addition of either 50 µl DPBS for the control vessels or the appropriate concentration of PE in 50 µl DPBS for experimental vessels. Antagonists were added 2 hr before agonists. After 22 hr vessels were washed six times with PSS of the following composition (mM): NaCl, 120; KCl, 4.7; MgCl2, 1.2; NaH2PO4, 1.0; NaHCO3, 25; CaCl2, 1.8; glucose, 11; EDTA, 0.024; and bubbled with 95%02/5%CO2.
Tail Artery Contraction
Tail arteries were placed into a Petri dish containing PSS and bubbled with 95%O2/5%CO2 while two stainless steel hooks were placed through each ring. Tail artery ring segments were mounted at 37°C in 20-ml organ baths by attaching the stainless steel hooks to gold chain connected to a force transducer at the top and to the bottom of the organ bath. Contraction was measured by force displacement transducers (Grass model FT.03) and a polygraph (Grass model 7D). Preparations were equilibrated in PSS for 60 min at a tension of 800 mg, which was previously determined to be optimal. Antagonists were administered 15 to 20 min before agonist.
Inositol Phosphate Accumulation
The method for measuring [3H]inositol
metabolism was described previously (Kendall and Hill, 1990
; Gurdal
et al., 1995
). Tail artery rings were prepared as described
above and preincubated in oxygenated buffer of the following
composition (mM): NaCl, 118; KCl, 4.7; MgSO4,
1.2; KH2PO4, 1.2;
NaHCO3, 25; CaCl2, 13 mM;
glucose, 10; HEPES, 15; pH 7.4 at 37°C for 1 hr. Subsequently, arterial segments were incubated for 1.5 hr in 20 µCi/ml of
[3H]myo-inositol (17 Ci/mmol, Dupont, NEN
Research Products, Boston, MA) containing buffer under the same
conditions. Labeled arterial segments were washed four times and placed
in individual tubes containing buffer with 10 mM LiCl (total assay
volume, 300 µl). Tail artery rings were incubated with agonist for 6 min, which was previously determined to be in the linear range of IP
accumulation and a time where precursor availability was not depleted.
Termination of the reaction was carried out by addition of 250 µl of
ice-cold 30% trichloroacetic acid. Tubes were then left on ice for 20 min. The tubes were then centrifuged (1500 × g 10 min)
and aliquots (350 µl) of supernatant were added to 125 µl of 10 mM
EDTA in 1.5-ml microcentrifuge tubes, followed by 500 µl of 1:1 Freon tri-n-octyl-amine. The samples were vortexed and allowed to
stand for 10 min before centrifugation (12,000 × g 10 min), and 300 µl of aqueous phase was taken for analysis of IPs.
Samples were loaded on Dowex-1(X8) ion exchange columns (formate form,
100-200 mesh, 1 ml). The columns were washed with 20 ml myo-inositol
(5 mM); the IPs were eluted with 4 ml of 0.1 M formic acid/1 M ammonium formate. Radioactivity was measured by liquid scintillation
spectrometry.
Preparation of Membranes
Tail arteries were placed in 20 mM NaH2PO4-Na2HPO4 buffer (pH 7.6) containing 154 mM NaCl, 0.04 mM phenylmethylsulfonyl fluoride, 50 µg/ml leupeptin, homogenized glass-to-glass with use of a motor-driven homogenizer and centrifuged at 500 × g for 10 min at 4°C. The supernatant was centrifuged at 100,000 × g for 60 min at 4°C. The resulting pellet was resuspended in PBS and used for binding assays.
Radioligand Binding
Saturation binding of [125I]HEAT (2200 Ci/mmol) was used to measure
1AR density. Tail
artery membranes were incubated with different concentrations of
[125I]HEAT in 200 µl PBS containing 0.01 mg/ml bovine serum albumin for 60 min at room temperature (20-30 µg
protein/tube). The reaction was terminated by rapid filtration with a
Brandell cell harvester and Whatman GF/C filters. Filters were washed
four times with 4 ml of ice-cold PBS. The filter-bound radioactivity
was determined using a Beckman gamma counter. Nonspecific binding is
defined as binding in the presence of 1 µM prazosin or 1 mM NE, with
equivalent results.
Agonist-Stimulated [35S]GTP
S Binding
and Immunoprecipitation
All procedures were carried out at 4°C unless otherwise
indicated. Crude tail artery membranes were prepared by homogenizing tissues in 10 volumes of ice-cold homogenization buffer containing 20 mM HEPES (pH 7.4), 100 mM EGTA, 0.2% 2-mercaptoethanol, 50 µg/ml
pepstatin A and 0.04 mM phenylmethylsulfonyl fluoride with a
glass-to-glass homogenizer. The homogenate was centrifuged for 10 min
at 48,200 × g. The pellet was resuspended in
oxygenated KRB: 25 mM HEPES (pH 7.4), 118 mM NaCl, 4.8 mM KCl, 1.2 mM
KH2PO4, 1.2 mM
MgSO4, 0.2% 2-mercaptoethanol, 50 µg/ml
leupeptin, 0.01 U/ml soybean trypsin inhibitor, 25 µg/ml pepstatin A
and 0.04 mM phenylmethylsulfonyl fluoride. Protein values were
determined by the method of Lowry et al. (1951)
. Membranes
(200 µg protein) were incubated with 2 nM
[35S]GTP
S for 5 min followed by an
additional 5-min incubation with agonists (total incubation volume, 250 µl). The reaction was terminated by diluting with 750 µl of
ice-cold Mg++-free, KRB containing 1 mM EGTA,
mixed, and immediately centrifuged at 16,000 × g for 5 min. The obtained pellets were solubilized in 500 µl IMP containing
100 mM Tris, pH 7.4, 1.25% (vol/vol) Nonidet P-40, 200 mM NaCl, 10 mM
EDTA, 50 µg/ml leupeptin, 0.01 U/ml soybean trypsin inhibitor, 25 µg/ml pepstatin A and 0.04 mM phenylmethylsulfonyl fluoride with
0.2% (w/v) SDS by brief sonication and an additional 500 µl IMP was
added to the suspension. The [35S]GTP
S-bound
G
proteins were immunoprecipitated by the
method described by Friedman et al. (1993)
. The pellets
containing [35S]GTP
S were resuspended in KRB
by brief sonication and radioactivity was measured by liquid
scintillation spectrometry. The radioactivity precipitated by the
normal rabbit serum was considered background and was subtracted from
all agonist-stimulated values.
Immunoblot Analysis
Tail artery membranes were prepared as described above in the
GTP
S binding assay and protein concentrations were determined by the
method of Lowry et al. (1951)
. Twenty-five micrograms of membrane proteins were separated by 10% SDS-polyacrylamide gel electrophoresis (Laemmli, 1970
) and then transferred
electrophoretically to nitrocellulose. Immunoblotting was performed
with antisera to G
q/11,
G
i, G
s and
G
o (NEN, dilutions 1:2000) and to common
G
(0.25 µg/ml, Santa Cruz) as described
previously (Carlson et al., 1989
; Spiegel, 1990
).
Nitrocellulose membranes were incubated overnight with 10% nonfat dry
milk in PBS containing 0.1% Tween-20 (0.1% TBS) at 4°C. Blots were
washed four times with 0.1% TBS (10 min each) and then incubated with
horseradish peroxidase-labeled donkey anti-rabbit IgG (Amersham,
Arlington Heights, IL) for 1 hr at room temperature. Blots were washed
once with 0.3% TBS for 15 min, followed by four 5-min washes with
0.1% TBS, then incubated with enhanced chemiluminescence Western
blotting reagent (Amersham) for 1 min and exposed to x-ray film for 15 to 30 sec.
Statistical Analysis
Results from the contraction, IP accumulation and GTP
S
binding studies were analyzed by two-factor ANOVA followed by
Neuman-Keuls test or Dunnett's test where appropriate or by planned
comparison with Student's t test. Radioligand binding data
were analyzed by the LIGAND program (Munson and Rodbard, 1980
; Munson,
1983
).
Materials
Normal rabbit serum and Pansorben were purchased from Calbiochem
(La Jolla CA). Antisera to G
s(RM/1),
G
i(1,2) (AS/7), G
o (GC/2) and
G
q (QL) were purchased from the New
England Nuclear Corp. (Boston, MA). [125I]HEAT
(2200 Ci/mmol) and [3H]myo-inositol (17Ci/mmol)
were purchased from the New England Nuclear Corp. (Boston, MA). 5-HT
creatinine sulfate, pepstatin A, phenylmethylsulfonyl fluoride and
soybean trypsin inhibitor were purchased from Sigma Chemical Co. (St.
Louis, MO). Dulbecco's PBS was purchased from GIBCO BRL Life
Technologies (Gaithersburg, MD). PE, clonidine, UK 14,304, prazosin
HCl, rauwolscine, were purchased from Research Biochemicals Inc. (RBI;
Natick, MA).
| |
Results |
|---|
|
|
|---|
Control experiments demonstrated that maintaining tail artery
rings in culture media for up to 72 hr did not adversely affect contractile responses (data not shown). Exposure of tail artery rings
to 7.5 µM or 75 µM PE for 22 hr shifted the concentration-response curve of NE-stimulated contraction to the right. The
pD2 values for NE-stimulated contraction were
6.63 ± 0.15, 6.11 ± 0.12 and 5.85 ± 0.26 for
DPBS-exposed, 7.5 µM PE-exposed and 75 µM PE-exposed tail artery
rings, respectively (P < .05) (fig.
1). The maximal NE-stimulated
contractions in the treated arteries were 1.74 ± 0.11 g,
1.28 ± 0.17 g and 1.02 ± 0.09 g, respectively
(P < .05) (fig. 1a). Prazosin (1 µM) treatment beginning 2 hr
before the addition of 7.5 µM PE completely abolished the shift in
pD2 values and maximal response to NE (data not
shown), which indicates that PE is acting at
1AR to produce desensitization.
|
Alpha-1 and alpha-2 adrenoceptors are found in
the rat tail artery, and both contribute to the contractile response
elicited by NE. To investigate whether contractile responses mediated
by
1AR and
2AR were
desensitized after incubation with PE, the selective
1AR agonist PE, and the
2AR agonists clonidine and UK 14,304 were
tested. The pD2 values (control: 6.25 ± 0.18 vs. PE: 5.30 ± 0.11, P < .01) and maximal
responses (control: 1.49 ± 0.14 g vs. PE:
0.78 ± 0.14 g, P < .01) for PE-stimulated contraction were significantly lower for tail artery rings exposed to 75 µM PE
for 22 hr when compared with control, DPBS-exposed, artery rings (fig.
2a). Clonidine, a partial
2AR agonist, produced no detectable
contraction in 75 µM PE-exposed tail artery rings, whereas control
vessels exposed to DPBS responded with a maximal contraction of
1.00 g (fig. 2b). Tail artery rings exposed to 75 µM PE also
exhibited decreases in the contractile responses to the full
2AR agonist, UK 14,304, at each of the three
concentrations (3 × 10
7 M,
70%; 10
6 M,
55%; and
10
5 M,
33%) examined (fig. 2c). To test
further the selectivity of the desensitization which is produced by
in vitro exposure to PE, the contractility of the vessels to
5-HT, KCl and ionomycin were also assessed. Although the contractile
response to 10 µM 5-HT was decreased by 28% after exposure to 75 µM PE, the responses to 60 mM KCl and 10 µM ionomycin did not
differ from those obtained in control tail artery rings (fig. 2d). The
data suggest that in vitro exposure to PE results in
desensitization of
1AR-,
2AR- and 5-HT receptor-stimulated contractions
of the vessels without a loss in vascular smooth muscle contractility.
|
One mechanism that mediates receptor-stimulated vascular contraction
involves activation of PLC and the production of
IP3 (Alexander et al., 1985
; Fox
et al., 1985
; Smith et al., 1985
). To determine
whether a reduction in receptor-stimulated activation of PLC occurs in
the tail artery during desensitization, agonist-stimulated IP
accumulation was measured after 22 hr exposure to PE (75 µM). Although basal IP formation in DPBS- and PE-exposed tail artery rings
did not differ (257 ± 28 cpm and 327 ± 41 cpm,
respectively), NE (1-30 µM)-stimulated IP accumulation was
significantly reduced (61-75%) in the desensitized vessels (fig.
3a). Stimulated PI hydrolysis in response
to the specific
1AR agonist, PE (10 µM), was
markedly diminished in tail artery rings exposed to 75 µM PE for 22 hr (519 ± 70% vs. 164 ± 54%; fig. 3b).
Serotonin (10 µM)- and endothelin (0.3 µM)-mediated PI responses
were also reduced (51% and 52% of control, respectively) in tail
artery rings which were pretreated with 75 µM PE for 22 hr (fig. 3b).
In contrast, 60 mM KCl- or 10 µM ionomycin-induced IP formation was
unaffected by the same treatment conditions (fig. 3b). The
2AR agonist, clonidine (10 µM), was unable
to stimulate measurable IP accumulation in DPBS- or PE-exposed tail
artery rings (data not shown). The latter finding is consistent with
the results of previous studies (Aburto et al., 1995
).
|
[125I]HEAT binding to
1AR was performed to determine whether
alterations in
1AR number contribute to the
desensitization produced by PE exposure. Saturation
[125I]HEAT binding revealed no difference in
1AR density in membranes of DPBS- or PE (75 µM)-exposed tail arteries (45.6 ± 15.0 and 37.3 ± 5.8 fmol/mg protein, respectively) (fig. 4),
which suggests that PE-mediated desensitization may result from changes
at a site(s) distal to the receptor. We therefore considered that both the homologous and heterologous desensitizations that were observed after 22 hr of PE-exposure may be mediated via changes at
the level of the G proteins that subserve the responses to the tested G
protein-coupled receptors. Experiments were therefore performed to
determine whether these receptors are associated with common G
protein(s) in the rat tail artery as well as to assess if alterations in receptor/G protein coupling occur during desensitization.
Receptor-stimulated binding of [35S]GTP
S to
specific membrane G proteins was determined in membranes of DPBS- or PE
(7.5 µM PE or 75 µM)-exposed rat tail artery rings. In control
tissue, PE increased [35S]GTP
S binding to
G
q/11 and
G
i, whereas stimulation of
2AR with UK 14,304 enhanced
[35S]GTP
S binding only to
G
i (fig.
5a). The results also demonstrate that
both PE- (10 µM) and UK 14,304 (10 µM)-mediated responses were
diminished after 22 hr exposure of the tail arteries to either 7.5 or
75 µM PE (fig. 5b). Immunoblot analyses with antibodies directed
against G
s,
G
i, G
o,
G
q/11 and G
proteins revealed decreases in G
q/11
(51% and 84%, respectively) and G
i
(32% and 70%, respectively) levels in membranes from PE-treated tail
arteries, whereas no changes in G
s,
G
o or G
were
noted (fig. 6).
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The current studies demonstrate that in vitro exposure
of the tail artery to prolonged
1AR
stimulation results in decreased receptor-mediated muscle contraction
and IP accumulation. The development of this functional desensitization
is mediated via direct stimulation of
1AR by PE, because it can be completely prevented by co-treatment of the tail artery with the
1AR antagonist, prazosin. The desensitization
to alpha receptor-stimulated contractile and IP responses
appear to be mediated at a site proximal to the receptor because KCl-
and ionomycin-activated contraction were not affected by PE treatment.
Moreover, the latter observations suggest that changes in
voltage-operated Ca++ channels or PLC activity
per se are probably not involved in the desensitization of
the rat tail artery, which develops during exposure to PE.
The results also indicate that desensitization is not related to
alterations at the level of the
1AR because
the density and affinity of [125I]HEAT binding
was not altered by prolonged incubation of vascular rings with PE. The
current results in the rat tail artery, as well as previous findings in
rat aorta, demonstrate that desensitization induced by
1AR stimulation results in a loss of function
that is not restricted to
1AR agonists (Maze
et al., 1985
; Rosenbaum et al., 1986
; Tsujimoto
et al., 1987
; Hu et al., 1994
). In this study,
tail artery contraction in response to clonidine, UK 14,304 and 5-HT
and IP accumulation in response to endothelin and 5-HT was reduced
after PE exposure. Similarly, heterologous desensitization was observed
previously in rat aorta showing that contraction and IP accumulation in
response to NE and AII are reduced after in vivo NE-infusion
(Seasholtz et al., 1997
). In the rat aorta, a lack of
alteration in
1AR receptor density during
desensitization was noted in both in vitro and in
vivo studies (Lurie et al., 1985
; Seasholtz et
al., 1997
). Thus, the desensitization resulting from protracted
stimulation of
1AR appears to be heterologous and is likely the result of an alteration at a site common to the
responsive G protein-coupled receptors that were examined.
A decrease in receptor-activated G proteins was noted after sustained
incubation of the rat tail artery with PE. In membranes obtained from
PE-exposed tail arteries, [35S]GTP
S binding
to G
proteins in response to
1-AR and
2-AR stimulation was blunted. In contrast to the results obtained in aorta
which indicate that in vivo NE infusion fails to affect G
levels (Seasholtz et al., 1997
)
or results in a small reduction in G
protein
(Zhou et al., 1995
), reductions in receptor-stimulated G
protein activation in the tail artery appear to be mediated by marked
decreases in levels of G
q and
G
i proteins which are associated with
prolonged stimulation of the
1AR. Thus, although uncoupling of receptors from their associated G proteins is
responsible for the functional desensitization in aorta after in
vivo infusion of NE (Johnson et al., 1991b
; Seasholtz
et al., 1997
), decreased G
subunits, which subsequently results in uncoupling of vasoactive
receptor/G protein, may account for the reduced receptor-mediated
contraction and IP accumulation observed in the tail artery after
in vitro PE exposure. In this regard, these findings are
similar to a recent study that demonstrated decreased levels of
G
q/11 subunits in
1AR-transfected rat fibroblasts after
prolonged exposure to PE (Wise et al., 1995
). Similarly,
sustained (6 hr) stimulation of rat aortic cells with arginine-vasopressin or AII also resulted in reduced cellular G
q/11 levels and heterologous
desensitization of the IP responses to AII and vasopressin (Kai
et al., 1996
). In the current study, these changes in G
protein tissue content appear to underlie the loss of
1AR-mediated functions as well as the reduced
responses to the other tested agonists of the G protein-coupled
receptors, 5-HT, alpha-2 and endothelin. These receptors,
therefore, appear to share common pools of membrane
G
proteins (Gq and
Gi) with those that couple to
1AR in the tail artery. Although it is
possible that the relatively high concentrations of the tested agonists
may induce contraction via activation of the
1AR, the fact that these agents activate
different subsets of G proteins and that the alpha-2
agonist, clonidine, did not increase IP accumulation suggest that
contractions induced by the alpha-1 and alpha-2
agonists and by 5-HT or endothelin are mediated by specific receptors
that are coupled to different G proteins and effectors. Furthermore, 5-HT-induced contraction in the tail artery was shown to be mediated by
5-HT2A receptors because contraction was blocked
specifically by ketanserin at concentrations that were selective for
the 5-HT2A receptor (Watts, 1996
).
In agreement with previous results in the rabbit saphenous vein (Aburto
et al., 1995
), we observed no
2AR-stimulated IP response in the rat tail
artery. Activation of
2ARs appears to elicit contraction solely via the influx of extracellular
Ca++ (Nichols and Ruffolo, 1988
; Nichols et
al., 1988
, 1989
; Aburto et al., 1995
). In contrast, the
contractile response mediated by
1AR involves
both Ca++ influx as well as intracellular
Ca++ release mediated by
IP3 receptors (Nichols and Ruffolo, 1988
; Nichols
et al., 1989
; Ruffolo et al., 1991
). Thus, a
direct relationship between receptor-stimulated blood vessel
contraction and IP accumulation is not always observed. Moreover,
1AR-stimulated contraction is only partially
pertussis toxin-sensitive, whereas
2AR-stimulated contraction can be completely
abolished by pertussis toxin (Nichols et al., 1989
; Ruffolo
et al., 1991
). These relationships between the adrenoceptor
subtypes and the functional response are supported by the present
direct evidence showing that the
2ARs are
coupled exclusively to Gi protein, whereas
1ARs are coupled to both
Gq and Gi proteins in the
rat tail artery. Because
2AR-stimulated GTP
S binding to G
i is reduced after
prolonged
1AR stimulation, it appears that
1 and
2ARs share the
same pool of Gi protein and this action underlies
the cross desensitization noted in the present work.
In summary, the present studies show that the responses of various
vasoactive G protein-coupled receptors are reduced after in
vitro exposure to PE for 22 hr. These changes are mediated by
reductions in G
protein levels which result in
impaired receptor/G protein/effector coupling. The studies furthermore suggest that in the tail artery, G protein-coupled receptors share membrane G
proteins and that this leads to the
heterologous desensitization which is produced by prolonged exposure to
an
1 receptor agonist.
| |
Footnotes |
|---|
Accepted for publication July 14, 1997.
Received for publication March 26, 1997.
1 This work was supported by grants awarded by Allegheny-Singer Research Institute; the American Heart Association, Southeastern Pennsylvania Affiliate; the American Heart Association, Delaware Valley Affiliate and National Institutes of Health, US Public Health Service AG14510.
2 Current address: Department of Pharmacology, Medical School of Ankara University, Sihhiye 06100 Ankara Turkey.
Send reprint requests to: Eitan Friedman, Ph.D., Division of Molecular Pharmacology, Department of Pharmacology, MCP - Hahnemann School of Medicine/EPPI, Allegheny University of the Health Sciences, 3200 Henry Avenue, Philadelphia, PA 19129.
| |
Abbreviations |
|---|
1AR, alpha-1
adrenoceptor;
2AR, alpha-2 adrenoceptor;
DPBS, Dulbecco's phosphate-buffered saline;
HEAT, 2-{[
-(4-hydroxyphenyl)ethyl]aminomethyl}-1-etralone;
5-HT, serotonin;
IMP, immunoprecipitation buffer;
IP, inositol phosphate;
IP3, inositol triphosphate;
KRB, Krebs-Ringer solution;
NE, norepinephrine;
PE, phenylephrine;
PLC, phospholipase C;
PBS, phosphate
buffered saline;
PSS, physiological saline solution;
SDS, sodium
dodecyl sulfate;
EDTA, ethylenediaminetetraacetic acid;
EGTA, ethyleneglycol-bis(
-aminoethyl ether)-N,N,N
,N
-tetraacetic acid;
HEPES, N-2-hydroxyethylpipeerazine-N
-2-ethanesulfonic acid;
ANOVA, analysis of variance.
| |
References |
|---|
|
|
|---|
1-adrenoceptor mediated responses during aging in Fisher 344 rats. J. Gerontol.: Biol.
Sci.
50: B67-B71, 1995.
-adrenergic-receptor-mediated smooth muscle contraction: Role of the endothelium.
J. Cardiovasc. Pharmacol.
18: 151-157, 1991.
1 adrenoceptors induces down-regulation of protein kinase C in vascular smooth muscle.
J. Cardiovasc. Pharmacol.
20: 982-989, 1992a.
-adrenergic agonists: Role in desensitization of smooth muscle contraction.
J. Cardiovasc. Pharmacol.
23: 337-343, 1994.
subunits in cultured vascular smooth muscle cells.
Mol. Pharmacol.
49: 96-104, 1996.
1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.
J. Biol. Chem.
262: 3098-3105, 1987.
-adrenoceptor reserve and agonist intrinsic efficacy to calcium utilization in the vasculature.
Trends Pharmacol. Sci.
9: 236-241, 1988.
2-adrenoceptors in the cardiovascular system of the pithed rat.
Eur. J. Pharmacol.
145: 345-349, 1988.
1- and
1-adrenoceptor function in the cardiovascular system of the pithed rat.
J. Pharmacol. Exp. Ther.
249: 203-209, 1989.
)-dobutamine, in pithed rats.
Fundam. Clin. Pharmacol.
5: 11-23, 1991.
1- and
2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma.
Circ. Res.
61: 86-89, 1987.
1-adrenoceptor in tail artery and aorta from spontaneously hypertensive and Wistar-Kyoto rats.
J. Cardiovasc. Pharmacol.
22: 191-197, 1993.
/Gq
is accelerated by agonist occupancy of
1A/D, and
1C adrenergic receptors.
J. Biol. Chem.
270: 17196-17203, 1995.This article has been cited by other articles:
![]() |
T. M. Seasholtz, G. Cai, H.-Y. Wang, and E. Friedman Signal Transduction in Smooth Muscle: Selected Contribution: Effects of ischemia-reperfusion on vascular contractility and {alpha}1-adrenergic-receptor signaling in the rat tail artery J Appl Physiol, August 1, 2001; 91(2): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz, M. Majumdar, D. D. Kaplan, and J. H. Brown Rho and Rho Kinase Mediate Thrombin-Stimulated Vascular Smooth Muscle Cell DNA Synthesis and Migration Circ. Res., May 28, 1999; 84(10): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||